NAPA Reauthorization Act
This act extends through 2035 and makes other changes to the National Alzheimer's Project. This project supports coordination of federal planning, programs, and other efforts to address Alzheimer's disease and related dementias.
In particular, the act incorporates a focus on promoting healthy aging and reducing risk factors associated with cognitive decline.
The act also expands the Advisory Council on Alzheimer's Research, Care, and Services to include additional members, such as (1) a researcher with experience recruiting and retaining diverse clinical trial participants, (2) an individual diagnosed with Alzheimer's disease, and (3) representatives from additional federal agencies (e.g., the Department of Justice).
NAPA Reauthorization Act
This bill extends through 2035 and makes other changes to the National Alzheimer's Project. This project supports coordination of federal planning, programs, and other efforts to address Alzheimer's disease and related dementias.
In particular, the bill incorporates a focus on promoting healthy aging and reducing risk factors associated with cognitive decline.
The bill also expands the Advisory Council on Alzheimer's Research, Care, and Services to include additional members, such as (1) a researcher with experience recruiting and retaining diverse clinical trial participants, (2) an individual diagnosed with Alzheimer's disease, and (3) representatives from additional federal agencies (e.g., the Department of Justice).
NAPA Reauthorization Act
This bill extends through 2035 and makes other changes to the National Alzheimer's Project. This project supports coordination of federal planning, programs, and other efforts to address Alzheimer's disease and related dementias.
In particular, the bill incorporates a focus on promoting healthy aging and reducing risk factors associated with cognitive decline.
The bill also expands the Advisory Council on Alzheimer's Research, Care, and Services to include additional members, such as (1) a researcher with experience recruiting and retaining diverse clinical trial participants, (2) an individual diagnosed with Alzheimer's disease, and (3) representatives from additional federal agencies (e.g., the Department of Justice).
NAPA Reauthorization Act
This bill extends through 2035 and makes other changes to the National Alzheimer's Project. This project supports coordination of federal planning, programs, and other efforts to address Alzheimer's disease and related dementias.
In particular, the bill incorporates a focus on promoting healthy aging and reducing risk factors associated with cognitive decline.
The bill also expands the Advisory Council on Alzheimer's Research, Care, and Services to include additional members, such as (1) a researcher with experience recruiting and retaining diverse clinical trial participants, (2) an individual diagnosed with Alzheimer's disease, and (3) representatives from additional federal agencies (e.g., the Department of Justice and the Office of Management and Budget).
Bucshon moved to suspend the rules and pass the bill.
(consideration: CR H5576-5577)
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5576-5577)
(text: CR H5576-5577)
(consideration: CR S5568-5569)
Passed Senate with an amendment by Voice Vote. (text: CR S5568-5569)
(text: CR S5568-5569)
Reported by Senator Sanders with an amendment in the nature of a substitute. Without written report.
Reported by Senator Sanders with an amendment in the nature of a substitute. Without written report.
Ordered to be reported with an amendment in the nature of a substitute favorably.